Unité de Fabrication des Médicaments S.A (BVMT:UMED)

Market Cap	340.16M +31.2%
Revenue (ttm)	148.91M +0.8%
Net Income	18.60M -4.0%
EPS	0.58 -4.0%
Shares Out	32.00M
PE Ratio	18.29
Forward PE	20.06
Dividend	0.57 (5.46%)
Ex-Dividend Date	Sep 9, 2026

Volume	41,564
Open	10.45
Previous Close	10.44
Day's Range	10.44 - 10.67
52-Week Range	7.90 - 10.74
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About BVMT:UMED

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally. The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name. It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia.

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 572
• Stock Exchange: Tunis Stock Exchange
• Ticker Symbol: UMED

Financial Performance

In 2025, BVMT:UMED's revenue was 148.91 million, an increase of 0.84% compared to the previous year's 147.68 million. Earnings were 18.60 million, a decrease of -3.98%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 17, 2026

Data Sources Report a data error